Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 19:16:1563229.
doi: 10.3389/fphar.2025.1563229. eCollection 2025.

A review on anti-cancer properties of quercetin in gastric cancer

Xiaoxia Xie  1 , Yan Wei  1
Affiliations
Review

A review on anti-cancer properties of quercetin in gastric cancer

Xiaoxia Xie et al. Front Pharmacol. .

Abstract

This review paper focuses on the multifaceted roles and therapeutic potential of quercetin in gastric cancer (GC). Quercetin, a natural flavonoid compound abundant in dietary sources such as nuts, teas, vegetables, and herbs, has garnered significant attention due to its anticancer properties. Accumulated evidence demonstrates quercetin's inhibitory effects against GC by targeting key pathways such as cell cycle regulation, fatty acid synthesis, and mitochondrial apoptosis, thereby exerting anti-proliferative and apoptotic strategies. Furthermore, quercetin effectively alleviates GC-related inflammation, optimizing the tumor microenvironment. Mechanistically, quercetin induces various forms of programmed cell death in GC cells, including ferroptosis, pyroptosis, and autophagy, through regulating specific molecular targets. Additionally, quercetin inhibits GC angiogenesis by downregulating vascular endothelial growth factor A (VEGF-A) and its receptor VEGFR-2 expression, and demonstrates anti-metastatic effects by modulating urokinase-type plasminogen activator (uPA) and its receptor (uPAR) function. As research delves deeper into the mechanisms of quercetin's actions and its validation in clinical trials, its prospects as a novel therapeutic agent for GC become increasingly promising. Quercetin's low toxicity and ability to synergize with other anticancer drugs make it a potential key component in comprehensive GC treatment strategies, significantly enhancing patient prognosis and quality of life.

Keywords: anti-inflammatory; anti-proliferation; cell death; gastric cancer; quercetin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The structural formula for quercetin.
FIGURE 2
FIGURE 2
Quercetin exerts dual effects on GC cells. On one hand, it suppresses GC progression through induction of apoptosis, pyroptosis, ferroptosis, as well as inhibition of migration, angiogenesis, and inflammation; on the other hand, it promotes GC cell survival by triggering protective autophagy.
FIGURE 3
FIGURE 3
The structural formula for 7-O-Geranylquercetin.
See this image and copyright information in PMC

References

    1. Ader P., Blöck M., Pietzsch S., Wolffram S. (2001). Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer. Lett. 162, 175–180. 10.1016/s0304-3835(00)00645-5 - DOI - PubMed
    1. Alizadeh S. R., Ebrahimzadeh M. A. (2022). Quercetin derivatives: drug design, development, and biological activities, a review. Eur. J. Med. Chem. 229, 114068. 10.1016/j.ejmech.2021.114068 - DOI - PubMed
    1. Boretti A. (2023). Quercetin as a cancer chemopreventive or chemotherapeutic agent: where we stand. Phytother. Res. 37, 1227–1231. 10.1002/ptr.7699 - DOI - PubMed
    1. Dai Z., Tan C., Wang J., Wang Q., Wang Y., He Y., et al. (2024). Traditional Chinese medicine for gastric cancer: an evidence mapping. Phytother. Res. 38, 2707–2723. 10.1002/ptr.8155 - DOI - PubMed
    1. Day A. J., Gee J. M., DuPont M. S., Johnson I. T., Williamson G. (2003). Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem. Pharmacol. 65, 1199–1206. 10.1016/s0006-2952(03)00039-x - DOI - PubMed

LinkOut - more resources